In Vivo Sun Protection Factor Determination

NCT ID: NCT02792595

Last Updated: 2016-06-20

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 28 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2015-06-30
• Study Completion Date: 2015-07-31

Brief Summary

The study aims to determine the Sun Protection Factor (SPF) of 8 cosmetic products in vivo on the back of human participants, according to the International Standard Sun Protection Test method by using a sun simulator.

Conditions

Skin Care

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: DOUBLE

Study Groups

Negative Control

Untreated area will be irradiated using a sun simulator with UV irradiation increment of 1.25 to detect MED of the unprotected skin.

Group Type: SHAM_COMPARATOR

Negative Control

Intervention Type: OTHER

Untreated area

Positive Control

After irradiation of the test area with a sun simulator with an increment of UV radiation of 1.25, positive control will be applied. The dose of positive control will be measured in accordance to the application volume (2 milligram (mg)/centimeter (cm)\^2 (± 0.05 mg/cm\^2) and it will be applied using a micro litre syringe in approximately 15-30 small droplets all over the test area. Positive control will be then quickly spread by gently rubbing with a non-saturated finger cot, first with rotating followed by crosswise movements for a final uniform coating on the skin. Spreading time will be between 20 and 50 seconds (s). After waiting for 15 to 30 minutes (min), the test area will be again irradiated (increment of 1.12 or 1.25) with the sun simulator. The irradiation time will depend on the SPF of positive control, participants' skin prototype, determined MED after irradiation and actual power of sun simulator.

Group Type: ACTIVE_COMPARATOR

Positive Control

Intervention Type: OTHER

High SPF Standard P3/SPF 15

Test Product A

After irradiation of the test area with a sun simulator with an increment of UV radiation of 1.25, test product will be applied. The dose of test product will be measured in accordance to the application volume (2 mg/cm\^2 (± 0.05 mg/cm\^2) and it will be applied using a micro litre syringe in approximately 15-30 small droplets all over the test area. Test product will be then quickly spread by gently rubbing with a non-saturated finger cot, first with rotating followed by crosswise movements for a final uniform coating on the skin. Spreading time will be between 20 and 50 s. After waiting for 15 to 30 min, the test area will be again irradiated (increment of 1.12 or 1.25) with the sun simulator. The irradiation time will depend on the expected SPF of the test product, participants' skin prototype, determined MED after irradiation and actual power of sun simulator.

Group Type: EXPERIMENTAL

Test Product A

Intervention Type: OTHER

Yosemite Falls (Forte Day SPF upgrade) Variant A

Test Product B

After irradiation of the test area with a sun simulator with an increment of UV radiation of 1.25, test product will be applied. The dose of test product will be measured in accordance to the application volume (2 mg/cm\^2 (± 0.05 mg/cm\^2) and it will be applied using a micro litre syringe in approximately 15-30 small droplets all over the test area. Test product will be then quickly spread by gently rubbing with a non-saturated finger cot, first with rotating followed by crosswise movements for a final uniform coating on the skin. Spreading time will be between 20 and 50 s. After waiting for 15 to 30 min, the test area will be again irradiated (increment of 1.12 or 1.25) with the sun simulator. The irradiation time will depend on the expected SPF of the test product, participants' skin prototype, determined MED after irradiation and actual power of sun simulator.

Group Type: EXPERIMENTAL

Test Product B

Intervention Type: OTHER

Yosemite Falls (Forte Day SPF upgrade) Variant B

Test Product C

After irradiation of the test area with a sun simulator with an increment of UV radiation of 1.25, test product will be applied. The dose of test product will be measured in accordance to the application volume (2 mg/cm\^2 (± 0.05 mg/cm\^2) and it will be applied using a micro litre syringe in approximately 15-30 small droplets all over the test area. Test product will be then quickly spread by gently rubbing with a non-saturated finger cot, first with rotating followed by crosswise movements for a final uniform coating on the skin. Spreading time will be between 20 and 50 s. After waiting for 15 to 30 min, the test area will be again irradiated (increment of 1.12 or 1.25) with the sun simulator. The irradiation time will depend on the expected SPF of the test product, participants' skin prototype, determined MED after irradiation and actual power of sun simulator.

Group Type: EXPERIMENTAL

Test Product C

Intervention Type: OTHER

Yosemite Falls (Forte Day SPF upgrade) Variant C

Test Product D

After irradiation of the test area with a sun simulator with an increment of UV radiation of 1.25, test product will be applied. The dose of test product will be measured in accordance to the application volume (2 mg/cm\^2 (± 0.05 mg/cm\^2) and it will be applied using a micro litre syringe in approximately 15-30 small droplets all over the test area. Test product will be then quickly spread by gently rubbing with a non-saturated finger cot, first with rotating followed by crosswise movements for a final uniform coating on the skin. Spreading time will be between 20 and 50 s. After waiting for 15 to 30 min, the test area will be again irradiated (increment of 1.12 or 1.25) with the sun simulator. The irradiation time will depend on the expected SPF of the test product, participants' skin prototype, determined MED after irradiation and actual power of sun simulator.

Group Type: EXPERIMENTAL

Test Product D

Intervention Type: OTHER

Yosemite Falls (Forte Day SPF upgrade) Variant D

Test Product E

After irradiation of the test area with a sun simulator with an increment of UV radiation of 1.25, test product will be applied. The dose of test product will be measured in accordance to the application volume (2 mg/cm\^2 (± 0.05 mg/cm\^2) and it will be applied using a micro litre syringe in approximately 15-30 small droplets all over the test area. Test product will be then quickly spread by gently rubbing with a non-saturated finger cot, first with rotating followed by crosswise movements for a final uniform coating on the skin. Spreading time will be between 20 and 50 s. After waiting for 15 to 30 min, the test area will be again irradiated (increment of 1.12 or 1.25) with the sun simulator. The irradiation time will depend on the expected SPF of the test product, participants' skin prototype, determined MED after irradiation and actual power of sun simulator.

Group Type: EXPERIMENTAL

Test Product E

Intervention Type: OTHER

Yosemite Falls (Forte Day SPF upgrade) Variant E

Test Product F

After irradiation of the test area with a sun simulator with an increment of UV radiation of 1.25, test product will be applied. The dose of test product will be measured in accordance to the application volume (2 mg/cm\^2 (± 0.05 mg/cm\^2) and it will be applied using a micro litre syringe in approximately 15-30 small droplets all over the test area. Test product will be then quickly spread by gently rubbing with a non-saturated finger cot, first with rotating followed by crosswise movements for a final uniform coating on the skin. Spreading time will be between 20 and 50 s. After waiting for 15 to 30 min, the test area will be again irradiated (increment of 1.12 or 1.25) with the sun simulator. The irradiation time will depend on the expected SPF of the test product, participants' skin prototype, determined MED after irradiation and actual power of sun simulator.

Group Type: EXPERIMENTAL

Test Product F

Intervention Type: OTHER

Yosemite Falls (Forte Day SPF upgrade) Variant F

Test Product G

After irradiation of the test area with a sun simulator with an increment of UV radiation of 1.25, test product will be applied. The dose of test product will be measured in accordance to the application volume (2 mg/cm\^2 (± 0.05 mg/cm\^2) and it will be applied using a micro litre syringe in approximately 15-30 small droplets all over the test area. Test product will be then quickly spread by gently rubbing with a non-saturated finger cot, first with rotating followed by crosswise movements for a final uniform coating on the skin. Spreading time will be between 20 and 50 s. After waiting for 15 to 30 min, the test area will be again irradiated (increment of 1.12 or 1.25) with the sun simulator. The irradiation time will depend on the expected SPF of the test product, participants' skin prototype, determined MED after irradiation and actual power of sun simulator.

Group Type: EXPERIMENTAL

Test Product G

Intervention Type: OTHER

Yosemite Falls (Forte Day SPF upgrade) Variant G

Test Product H

After irradiation of the test area with a sun simulator with an increment of UV radiation of 1.25, test product will be applied. The dose of test product will be measured in accordance to the application volume (2 mg/cm\^2 (± 0.05 mg/cm\^2) and it will be applied using a micro litre syringe in approximately 15-30 small droplets all over the test area. Test product will be then quickly spread by gently rubbing with a non-saturated finger cot, first with rotating followed by crosswise movements for a final uniform coating on the skin. Spreading time will be between 20 and 50 s. After waiting for 15 to 30 min, the test area will be again irradiated (increment of 1.12 or 1.25) with the sun simulator. The irradiation time will depend on the expected SPF of the test product, participants' skin prototype, determined MED after irradiation and actual power of sun simulator.

Group Type: EXPERIMENTAL

Test Product H

Intervention Type: OTHER

Yosemite Falls (Forte Day SPF upgrade) Variant H

Interventions

Negative Control

Untreated area

Intervention Type: OTHER

Positive Control

High SPF Standard P3/SPF 15

Intervention Type: OTHER

Test Product A

Yosemite Falls (Forte Day SPF upgrade) Variant A

Intervention Type: OTHER

Test Product B

Yosemite Falls (Forte Day SPF upgrade) Variant B

Intervention Type: OTHER

Test Product C

Yosemite Falls (Forte Day SPF upgrade) Variant C

Intervention Type: OTHER

Test Product D

Yosemite Falls (Forte Day SPF upgrade) Variant D

Intervention Type: OTHER

Test Product E

Yosemite Falls (Forte Day SPF upgrade) Variant E

Intervention Type: OTHER

Test Product F

Yosemite Falls (Forte Day SPF upgrade) Variant F

Intervention Type: OTHER

Test Product G

Yosemite Falls (Forte Day SPF upgrade) Variant G

Intervention Type: OTHER

Test Product H

Yosemite Falls (Forte Day SPF upgrade) Variant H

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Understanding of the study and willingness to participate as demonstrated by voluntary written informed consent
• Age between 18 to 70 years (inclusive)
• Uniform skin and no erythema or dark pigmentation in the test area
• Skin type I, II or III according to Fitzpatrick scale
• Individual typological angle (ITA°) > 28 in the test area
• Willingness to discontinue the use of detergents, cosmetic products in the treatment areas and to avoid any exposure of the test area to artificial or natural ultraviolet (UV) light throughout the study

Exclusion Criteria

• Breast feeding, pregnant women or who are intending to become pregnant over study duration
• Acquired immunodeficiency syndrome (AIDS) or infectious hepatitis, insulin dependent diabetes, cancer, active skin disease at the test area, asthma or hypertension if not medicated, medical history of dysplastic nevi or melanoma, allergies to cosmetic products
• Electronic implant that cannot be removed during irradiation
• Sun exposition, UV therapy, artificial tanning within the last 4 weeks, or irregularly tanned skin in the test area
• Application of leave-on cosmetics at the test area within the last 24 h prior to the study start
• Moles, tattoos, scars, irritated skin, hair, etc. at the test area that could influence the investigation
• Usage of medications with known photo-toxic and/or photo-sensitizing potential within the last 14 days prior to study start and/or throughout the entire study course
• Systemic therapy with immuno-suppresive drugs and/or antihistamines within last 7 days prior to study start and/or throughout the entire study course
• Systemic therapy with anti-phlogistic agents or analgetics within last 3 days prior to study start and/or throughout the entire study course
• Participation or in waiting period of 2 months after participation in similar cosmetic and/or pharmaceutical UV studies
• Known or suspected intolerance or hypersensitivity to cosmetic products
• Alcohol or other substance of abuse within the last 5 years
• Employee of the sponsor or the study site or members of their immediate family

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 70 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

GlaxoSmithKline

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

GSK Clinical Trials

Role: STUDY_DIRECTOR

GlaxoSmithKline

Locations

GSK Investigational Site

Schenefeld, Schleswig-Holstein, Germany

Countries

Germany

Other Identifiers

204736

Identifier Type: -

Identifier Source: org_study_id